{"title":"다음 뉴스 ─ 전체기사 ─ 칼럼","url":"https://news.daum.net/breakingnews/editorial","favicon":"https://news.daum.net/breakingnews/favicon.ico","elements":[{"title":"[세평]  암(癌) 그리고 앎-5","contents":"대전일보<span class=\"txt_bar\"> · </span><span class=\"info_time\">07:08</span>","link":"https://v.daum.net/v/20220216070838639","retrieved":1644963478901},{"title":"[기자수첩]  헤아리지 못한 마음","contents":"대전일보<span class=\"txt_bar\"> · </span><span class=\"info_time\">07:08</span>","link":"https://v.daum.net/v/20220216070836638","retrieved":1644963478901},{"title":"[한밭춘추]  낯섦과 친해지기②","contents":"대전일보<span class=\"txt_bar\"> · </span><span class=\"info_time\">07:08</span>","link":"https://v.daum.net/v/20220216070835637","retrieved":1644963478902},{"title":"[아름다운건축] 건축적 배려","contents":"대전일보<span class=\"txt_bar\"> · </span><span class=\"info_time\">07:08</span>","link":"https://v.daum.net/v/20220216070833636","retrieved":1644963478905},{"title":"[전문인칼럼] 건축사와 의무가입","contents":"대전일보<span class=\"txt_bar\"> · </span><span class=\"info_time\">07:08</span>","link":"https://v.daum.net/v/20220216070832634","retrieved":1644963478906},{"title":"[시론]기업 혁신 가로막는 정부 규제 정비해야","contents":"서울경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">07:00</span>","link":"https://v.daum.net/v/20220216070048504","retrieved":1644963478907},{"title":"[김성현 칼럼]우리는 얼마나 큰 정부를 원하나?","contents":"서울경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">07:00</span>","link":"https://v.daum.net/v/20220216070041496","retrieved":1644963478909},{"title":"[시로 여는 수요일]눈사람","contents":"서울경제<span class=\"txt_bar\"> · </span><span class=\"info_time\">07:00</span>","link":"https://v.daum.net/v/20220216070036490","retrieved":1644963478909},{"title":"오늘 9만명 확진 예상..18일 거리두기 조정안 발표","contents":"한국경제TV<span class=\"txt_bar\"> · </span><span class=\"info_time\">06:45</span>","link":"https://v.daum.net/v/20220216064501271","retrieved":1644963478910},{"title":"No return to the past (KOR)","contents":"코리아중앙데일리<span class=\"txt_bar\"> · </span><span class=\"info_time\">06:38</span>","link":"https://v.daum.net/v/20220216063824205","retrieved":1644963478911},{"title":"Where's the beef? (KOR)","contents":"코리아중앙데일리<span class=\"txt_bar\"> · </span><span class=\"info_time\">06:36</span>","link":"https://v.daum.net/v/20220216063645194","retrieved":1644963478913},{"title":"[특별기고]혁신중기의 실패·재도전 응원해야","contents":"이데일리<span class=\"txt_bar\"> · </span><span class=\"info_time\">06:30</span>","link":"https://v.daum.net/v/20220216063006097","retrieved":1644963478915},{"title":"[이코노믹 view]주식투자, 눈높이 낮춰라","contents":"이데일리<span class=\"txt_bar\"> · </span><span class=\"info_time\">06:15</span>","link":"https://v.daum.net/v/20220216061505907","retrieved":1644959725073},{"title":"[기자수첩] 문샷株의 추락과 제주맥주, 마켓컬리","contents":"조선비즈<span class=\"txt_bar\"> · </span><span class=\"info_time\">06:01</span>","link":"https://v.daum.net/v/20220216060102616","retrieved":1644959725074},{"title":"[기자수첩] '제약바이오' 강성주주와 설레발, 인과관계의 딜레마","contents":"뉴시스<span class=\"txt_bar\"> · </span><span class=\"info_time\">06:00</span>","link":"https://v.daum.net/v/20220216060048582","retrieved":1644959725075}]}